80 FR 22557 - Bulk Manufacturer of Controlled Substances Application: Cayman Chemicals Company
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 77 (April 22, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 77 (April 22, 2015)
| Page Range | 22557-22558 | |
| FR Document | 2015-09329 |
[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)] [Notices] [Pages 22557-22558] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-09329] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Cayman Chemicals Company ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 22, 2015. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 24, 2014, Cayman Chemical Company, 1180 [[Page 22558]] East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC) (1233).. I Cathinone (1235)........................... I Methcathinone (1237)....................... I 4-Fluoro-N-methylcathinone (4-FMC) (1238).. I Pentedrone ([alpha]- I methylaminovalerophenone) (1246). Mephedrone (4-Methyl-N-methylcathinone) I (1248). 4-Methyl-N-ethylcathinone (4-MEC) (1249)... I Naphyrone (1258)........................... I N-Ethylamphetamine (1475).................. I N,N-Dimethylamphetamine (1480)............. I Aminorex (1585)............................ I 4-Methylaminorex (cis isomer) (1590)....... I Gamma Hydroxybutyric Acid (2010)........... I JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) I indole) (6250). SR-18 (Also known as RCS-8) (1- I Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008). 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- I pentyl) 1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (7011). AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- I 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3- carboxamide) (7012). JWH-019 (1-Hexyl-3-(1-naphthoyl) indole) I (7019). ADB-PINACA (N-(1-amino-3,3-dimethyl-1- I oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide) (7035). APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- I 1H-indazole-3-carboxamide (7048). JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) I indole) (7081). SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- I methoxy)-benzoyl] indole (7104). JWH-018 (also known as AM678) (1-Pentyl-3- I (1-naphthoyl) indole) (7118). JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) I indole) (7122). UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- I tetramethylcyclopropyl)methanone (7144). JWH-073 (1-Butyl-3-(1-naphthoyl)indole I (7173). JWH-200(1-[2-(4-Morpholinyl)ethyl]-3-(1- I naphthoyl) indole) (7200). AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) I indole) (7201). JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) I indole) (7203). PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I carboxylate) (7222). 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- I 1H-indole-3-carboxylate) (7225). Alpha-ethyltryptamine (7249)............... I CP-47,497 (5-(1,1-Dimethylheptyl)-2- I [(1R,3S)-3-hydroxycyclohexyl-phenol (7297). CP-47,497 C8 Homologue (5-(1,1- I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol) (7298). Lysergic acid diethylamide (7315).......... I 2,5-Dimethoxy-4-(n)- I propylthiophenethylamine) (2C-T-7) (7348). Marihuana (7360)........................... I Tetrahydrocannabinols (7370)............... I Mescaline (7381)........................... I 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine. (2C-T-2) (7385)............................ I 3,4,5-Trimethoxyamphetamine (7390)......... I 4-Bromo-2,5-dimethoxyamphetamine (7391).... I 4-Bromo-2,5-dimethoxyphenethylamine (7392). I 4-Methyl-2,5-dimethoxyamphetamine (7395)... I 2,5-Dimethoxyamphetamine (7396)............ I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) I indole (7398). 2,5-Dimethoxy-4-ethylamphetamine (7399).... I 3,4-Methylenedioxyamphetamine (7400)....... I 5-Methoxy-3,4-methylenedioxyamphetamine I (7401). N-Hydroxy-3,4-methylenedioxyamphetamine I (7402). 3,4-Methylenedioxy-N-ethylamphetamine I (7404). 3,4-Methylenedioxymethamphetamine (7405)... I 4-Methoxyamphetamine (7411)................ I 5-Methoxy-N-N-dimethyltryptamine (7431).... I Alpha-methyltryptamine (7432).............. I Bufotenine (7433).......................... I Diethyltryptamine (7434)................... I Dimethyltryptamine (7435).................. I Psilocybin (7437).......................... I Psilocyn (7438)............................ I 5-Methoxy-N,N-diisopropyltryptamine (7439). I N-Benzylpiperazine (7493).................. I 4-Methyl-alphapyrrolidinopropiophenone (4- I MePPP) (7498). 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine I (2C-D) (7508). 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine I (2C-E) (7509). 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) I (7517). 2-(4-lodo-2,5-dimethoxyphenyl) ethanamine I (2C-I) (7518). 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine I (2C-C) (7519). 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine I (2C-N) (7521). 2-(2,5-Dimethoxy-4-(n)-propylphenyl) I ethanamine (2C-P) (7524). 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) I ethanamine (2C-T-4) (7532). MDPV (3,4-Methylenedioxypyrovalerone) I (7535). Methylone (3,4-Methylenedioxy-N- I methylcathinone) (7540). Butylone (7541)............................ I Pentylone (7542)........................... I alpha-pyrrolidinopentiophenone ([alpha]- I PVP) (7545). alpha-pyrrolidinobutiophenone ([alpha]-PBP) I (7546). AM-694 (1-(5-Fluoropentyl)-3-(2- I iodobenzoyl) indole) (7694). Desomorphine (9055)........................ I Dihydromorphine (9145)..................... I Heroin (9200).............................. I Morphine-N-oxide (9307).................... I Normorphine (9313)......................... I Tilidine (9750)............................ I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Lisdexamfetamine (1205).................... II Pentobarbital (2270)....................... II Phencyclidine (7471)....................... II Phenylacetone (8501)....................... II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Hydrocodone (9193)......................... II Levomethorphan (9210)...................... II Meperidine (9230).......................... II Meperidine intermediate-B (9233)........... II Methadone (9250)........................... II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Morphine (9300)............................ II Thebaine (9333)............................ II Oxymorphone (9652)......................... II Sufentanil (9740).......................... II ------------------------------------------------------------------------ The company plans to manufacture reference standards for distribution to their research and forensics customers. In reference to drug codes 7360 Marihuana, and 7370 (THC), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: April 14, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015-09329 Filed 4-21-15; 8:45 am] BILLING CODE P
![Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 22557
5, 2015, Almac Clinical Services Inc., revocation of registration) has been Controlled substance Schedule
(ACSI), 25 Fretz Road, Souderton, redelegated to the Deputy Assistant
Pennsylvania 18964 applied to be Administrator of the DEA Office of Levo-alphacetylmethadol (9648) .. II
registered as an importer of the Diversion Control (‘‘Deputy Assistant Remifentanil (9739) ...................... II
following basic classes of controlled Administrator’’) pursuant to section 7 of Sufentanil (9740) .......................... II
substances: 28 CFR part 0, appendix to subpart R. Carfentanil (9743) ......................... II
In accordance with 21 CFR Fentanyl (9801) ............................ II
1301.33(a), this is notice that on January
2, 2015, Sigma Aldrich Research The company plans to manufacture
Controlled substance Schedule reference standards.
Biochemicals, Inc., 1–3 Strathmore
Oxycodone (9143) ........................ II Road, Natick, Massachusetts 01760– Dated: April 14, 2015.
Hydromorphone (9150) ................ II 2447 applied to be registered as a bulk Joseph T. Rannazzisi,
Tapentadol (9780) ........................ II manufacturer of the following basic Deputy Assistant Administrator.
Fentanyl (9801) ............................ II classes of controlled substances: [FR Doc. 2015–09328 Filed 4–21–15; 8:45 am]
The company plans to import small BILLING CODE 4410–09–P
Controlled substance Schedule
quantities of the listed controlled
substances in dosage form to conduct Cathinone (1235) .......................... I
DEPARTMENT OF JUSTICE
clinical trials. Methcathinone (1237) .................. I
Mephedrone (4-Methyl-N- I
Dated: April 14, 2015. methylcathinone) (1248). Drug Enforcement Administration
Joseph T. Rannazzisi, Aminorex (1585) ........................... I [Docket No. DEA–392]
Deputy Assistant Administrator. Alpha-ethyltryptamine (7249) ....... I
[FR Doc. 2015–09333 Filed 4–21–15; 8:45 am] Lysergic acid diethylamide (7315) I Bulk Manufacturer of Controlled
Tetrahydrocannabinols (7370) ..... I Substances Application: Cayman
BILLING CODE 4410–09–P
4-Bromo-2,5- I
dimethoxyamphetamine (7391).
Chemicals Company
4-Bromo-2,5- I
DEPARTMENT OF JUSTICE dimethoxyphenethylamine
ACTION: Notice of application.
(7392).
Drug Enforcement Administration 4-Methyl-2,5- I DATES: Registered bulk manufacturers of
dimethoxyamphetamine (7395). the affected basic classes, and
[Docket No. DEA–392]
2,5-Dimethoxyamphetamine I applicants therefore, may file written
Bulk Manufacturer of Controlled (7396). comments on or objections to the
3,4-Methylenedioxyamphetamine I issuance of the proposed registration in
Substances Application: Sigma Aldrich (7400).
Research Biochemicals, Inc. accordance with 21 CFR 1301.33(a) on
N-Hydroxy-3,4- I or before June 22, 2015.
methylenedioxyamphetamine
ACTION: Notice of application. (7402). ADDRESSES: Written comments should
3,4-Methylenedioxy-N- I be sent to: Drug Enforcement
DATES: Registered bulk manufacturers of ethylamphetamine (7404). Administration, Attention: DEA Federal
the affected basic classes, and 3,4- I Register Representative/ODXL, 8701
applicants therefore, may file written Methylenedioxymethamphetam- Morrissette Drive, Springfield, Virginia
comments on or objections to the ine (7405). 22152. Request for hearings should be
issuance of the proposed registration in Dimethyltryptamine (7435) ........... I
Psilocybin (7437) .......................... I
sent to: Drug Enforcement
accordance with 21 CFR 1301.33(a) on Administration, Attention: Hearing
5-Methoxy-N,N- I
or before June 22, 2015. diisopropyltryptamine (7439). Clerk/LJ, 8701 Morrissette Drive,
ADDRESSES: Written comments should 1-[1-(2- I Springfield, Virginia 22152.
be sent to: Drug Enforcement Thienyl)cyclohexyl]piperidine SUPPLEMENTARY INFORMATION: The
Administration, Attention: DEA Federal (7470). Attorney General has delegated his
Register Representative/ODXL, 8701 N-Benzylpiperazine (7493) ........... I
MDPV (3,4- I
authority under the Controlled
Morrissette Drive, Springfield, Virginia Substances Act to the Administrator of
Methylenedioxypyrovalerone)
22152. Request for hearings should be (7535). the Drug Enforcement Administration
sent to: Drug Enforcement Methylone (3,4-Methylenedioxy-N- (DEA), 28 CFR 0.100(b). Authority to
Administration, Attention: Hearing methylcathinone). exercise all necessary functions with
Clerk/LJ, 8701 Morrissette Drive, (7540) ........................................... I respect to the promulgation and
Springfield, Virginia 22152. Heroin (9200) ............................... I implementation of 21 CFR part 1301,
SUPPLEMENTARY INFORMATION: The Normorphine (9313) ..................... I incident to the registration of
Amphetamine (1100) .................... II
Attorney General has delegated his Methamphetamine (1105) ............ II
manufacturers, distributors, dispensers,
authority under the Controlled Nabilone (7379) ............................ II importers, and exporters of controlled
Substances Act to the Administrator of 1-Phenylcyclohexylamine (7460) II substances (other than final orders in
the Drug Enforcement Administration Phencyclidine (7471) .................... II connection with suspension, denial, or
(DEA), 28 CFR 0.100(b). Authority to Cocaine (9041) ............................. II revocation of registration) has been
asabaliauskas on DSK5VPTVN1PROD with NOTICES
exercise all necessary functions with Codeine (9050) ............................. II redelegated to the Deputy Assistant
respect to the promulgation and Ecgonine (9180) ........................... II Administrator of the DEA Office of
implementation of 21 CFR part 1301, Levomethorphan (9210) ............... II Diversion Control (‘‘Deputy Assistant
Levorphanol (9220) ...................... II
incident to the registration of Meperidine (9230) ........................ II
Administrator’’) pursuant to section 7 of
manufacturers, distributors, dispensers, Metazocine (9240) ........................ II 28 CFR part 0, appendix to subpart R.
importers, and exporters of controlled Methadone (9250) ........................ II In accordance with 21 CFR
substances (other than final orders in Morphine (9300) ........................... II 1301.33(a), this is notice that on July 24,
connection with suspension, denial, or Thebaine (9333) ........................... II 2014, Cayman Chemical Company, 1180
VerDate Sep<11>2014 18:00 Apr 21, 2015 Jkt 235001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\22APN1.SGM 22APN1](https://thefederalregister.org/doc/80_FR_22634/page/1.svg)
 ............. II
tetramethylcyclopropyl) (7396). Pentobarbital (2270) ..................... II
methanone (7011). JWH-398 (1-Pentyl-3-(4-chloro-1- I Phencyclidine (7471) .................... II
AB-FUBINACA (N-(1-amino-3- I naphthoyl) indole (7398). Phenylacetone (8501) .................. II
methyl-1-oxobutan-2-yl)-1-(4- 2,5-Dimethoxy-4- I Codeine (9050) ............................. II
fluorobenzyl)-1H-indazole-3- ethylamphetamine (7399). Dihydrocodeine (9120) ................. II
carboxamide) (7012). 3,4-Methylenedioxyamphetamine I Oxycodone (9143) ........................ II
JWH-019 (1-Hexyl-3-(1-naphthoyl) I (7400). Hydromorphone (9150) ................ II
indole) (7019). 5-Methoxy-3,4- I Hydrocodone (9193) ..................... II
ADB-PINACA (N-(1-amino-3,3-di- I methylenedioxyamphetamine
methyl-1-oxobutan-2-yl)-1- Levomethorphan (9210) ............... II
(7401). Meperidine (9230) ........................ II
pentyl-1H-indazole-3- N-Hydroxy-3,4- I
carboxamide) (7035). Meperidine intermediate-B (9233) II
methylenedioxyamphetamine
APINACA and AKB48 N-(1- I Methadone (9250) ........................ II
(7402).
Adamantyl)-1-pentyl-1H-inda- Dextropropoxyphene, bulk (non- II
3,4-Methylenedioxy-N- I
zole-3-carboxamide (7048). dosage forms) (9273).
ethylamphetamine (7404).
JWH-081 (1-Pentyl-3-(1-(4- I Morphine (9300) ........................... II
3,4- I
methoxynaphthoyl) indole) Methylenedioxymethamphetam- Thebaine (9333) ........................... II
(7081). ine (7405). Oxymorphone (9652) ................... II
SR-19 (Also known as RCS-4) (1- I 4-Methoxyamphetamine (7411) ... I Sufentanil (9740) .......................... II
Pentyl-3-[(4-methoxy)-benzoyl] 5-Methoxy-N-N- I
indole (7104). dimethyltryptamine (7431). The company plans to manufacture
JWH-018 (also known as AM678) I Alpha-methyltryptamine (7432) .... I reference standards for distribution to
(1-Pentyl-3-(1-naphthoyl) Bufotenine (7433) ......................... I
indole) (7118).
their research and forensics customers.
Diethyltryptamine (7434) .............. I
JWH-122 (1-Pentyl-3-(4-methyl-1- I Dimethyltryptamine (7435) ........... I In reference to drug codes 7360
naphthoyl) indole) (7122). Psilocybin (7437) .......................... I Marihuana, and 7370 (THC), the
UR-144 (1-Pentyl-1H-indol-3- I Psilocyn (7438) ............................. I company plans to bulk manufacture
yl)(2,2,3,3- 5-Methoxy-N,N- I
asabaliauskas on DSK5VPTVN1PROD with NOTICES
these drugs as synthetic. No other
tetramethylcyclopropy- diisopropyltryptamine (7439). activities for these drug codes are
l)methanone (7144). N-Benzylpiperazine (7493) ........... I
JWH-073 (1-Butyl-3-(1-naph- I 4-Methyl- I
authorized for this registration.
thoyl)indole (7173). alphapyrrolidinopropiophenone Dated: April 14, 2015.
JWH-200(1-[2-(4- I (4-MePPP) (7498). Joseph T. Rannazzisi,
Morpholinyl)ethyl]-3-(1-naph- 2-(2,5-Dimethoxy-4-methylphenyl) I
Deputy Assistant Administrator.
thoyl) indole) (7200). ethanamine (2C-D) (7508).
AM-2201 (1-(5-Fluoropentyl)-3-(1- I 2-(2,5-Dimethoxy-4-ethylphenyl) I [FR Doc. 2015–09329 Filed 4–21–15; 8:45 am]
naphthoyl) indole) (7201). ethanamine (2C-E) (7509). BILLING CODE P
VerDate Sep<11>2014 18:00 Apr 21, 2015 Jkt 235001 PO 00000 Frm 00086 Fmt 4703 Sfmt 9990 E:\FR\FM\22APN1.SGM 22APN1](https://thefederalregister.org/doc/80_FR_22634/page/2.svg)
Document Created: 2015-12-16 08:28:04
Document Modified: 2015-12-16 08:28:04
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 22, 2015. | |
| FR Citation | 80 FR 22557 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR